Cryptosporidium hominis: Difference between revisions
From IDWiki
Cryptosporidium hominis
(→: added subpopulations) |
(added Dx and Mx sections) |
||
Line 2: | Line 2: | ||
* Similar to [[Cryptosporidium parvum]] which typically infects cows, but can also infect humans |
* Similar to [[Cryptosporidium parvum]] which typically infects cows, but can also infect humans |
||
== |
== Background == |
||
=== Microbiology === |
|||
* Protozoan parasite in the genus [[Cryptosporidium species|''Cryptosporidium'']] |
* Protozoan parasite in the genus [[Cryptosporidium species|''Cryptosporidium'']] |
||
== Epidemiology == |
=== Epidemiology === |
||
* Infects humans, but can also infect cows, mice, gnotobiotic pigs, and rarely other species |
* Infects humans, but can also infect cows, mice, gnotobiotic pigs, and rarely other species |
||
Line 16: | Line 18: | ||
** Causes 2-6% of traveller's diarrhea |
** Causes 2-6% of traveller's diarrhea |
||
== Life Cycle == |
=== Life Cycle === |
||
* Host ingests an '''oocyst''' (needing as few as 10 to cause disease) |
* Host ingests an '''oocyst''' (needing as few as 10 to cause disease) |
||
Line 29: | Line 31: | ||
* Oocysts may be involved in auto-inoculation (if thin-walled) or environmental contamination (if thick-walled) |
* Oocysts may be involved in auto-inoculation (if thin-walled) or environmental contamination (if thick-walled) |
||
== Pathophysiology == |
=== Pathophysiology === |
||
* Infection activates nuclear factor kappa B (NF-κB), which activates a large response |
* Infection activates nuclear factor kappa B (NF-κB), which activates a large response |
||
Line 60: | Line 62: | ||
* May also involve extraintestinal cryptosporidiosis, such as biliary or respiratory disease |
* May also involve extraintestinal cryptosporidiosis, such as biliary or respiratory disease |
||
=== Other immunocompromised patients === |
|||
* May present similarly to HIV |
|||
* Includes solid organ transplant, hematopoietic stem cell transplant, and hyper-IgM syndrome |
|||
== Diagnosis == |
|||
* Stool antigen |
|||
* Stool with immunofluorescence or with acid-fast staining (70% sensitive) |
|||
* PCR |
|||
== Management == |
|||
* Supportive care, including fluids and antimotility agents like loperamide |
|||
* In immunocompetent hosts: [[Is treated by::nitazoxanide]] 500 mg po tid for 3 days |
|||
* In severely immunocompromised patients, may not be curable without reversing immunosuppression |
|||
{{DISPLAYTITLE:''Cryptosporidium hominis''}} |
{{DISPLAYTITLE:''Cryptosporidium hominis''}} |
Revision as of 23:15, 9 October 2019
- A member of the Cryptosporidium species which causes diarrheal disease in humans
- Similar to Cryptosporidium parvum which typically infects cows, but can also infect humans
Background
Microbiology
- Protozoan parasite in the genus Cryptosporidium
Epidemiology
- Infects humans, but can also infect cows, mice, gnotobiotic pigs, and rarely other species
- Transmitted fecal-oral via environmental contamination (such as recreational water), and can be spread person-to-person
- Outbreaks are most commonly associated with drinking water, even when properly treated
- Resistant to chlorination and can survive in the environment up to 6 months
- In developing countries, primarily affects children less than 5 years
- In developed countries, primarily affects adults, related to travel
- Causes 2-6% of traveller's diarrhea
Life Cycle
- Host ingests an oocyst (needing as few as 10 to cause disease)
- The oocyst excyst in the stomach and proximal small bowel, releasing four sporozoites
- Sporozoites bind to the intestinal epithelial cells and becomes vacuolized by the host cell membrane
- In the parasitophorous vacuole, they reproduce asexually into further sporozoites, which divide into type I meronts
- The type I meronts mature and release motile merozoites
- The merozoites again attach to the intestinal epithelial cells
- Merozoites then either reproduce asexually, as above, or sexually
- Sexual reproduction involves a macrogamont and microgamont, which form a zygote
- The zygote develops into an oocyst which contains four sporozoites
- Oocysts may be involved in auto-inoculation (if thin-walled) or environmental contamination (if thick-walled)
Pathophysiology
- Infection activates nuclear factor kappa B (NF-κB), which activates a large response
- Infection results in increased permeability of the intestinal mucosa
- T-cells are involved, with chronic infection in patients who are CD4-deplete
Clinical Presentation
- Incubation period 7 days (range 1 to 30 days)
Immunocompetent adults
- Associated with waterborne outbreaks, travel, animal contacts, or child contacts
- Watery (to mucoid) diarrhea and malabsorption
- May also have abdominal cramping, nausea or vomiting, and fever
- Lasts 5 to 14 days, but up to 100
- However, recurs in about 40% and can become an intermittent or chronic diarrhea similar to irritable bowel syndrome
Childhood diarrhea
- Causes about 10-15% of acute childhood diarrhea in developing countries
- Presents with watery diarrhea, cramps, and nausea and vomiting
- May also have fever, cough, dyspnea, and foul-smelling stool
- Can turn into chronic diarrhea and malabsorption
People living with HIV
- Most cases are asymptomatic or mild and self-limited
- Chronic infection more common in HIV with CD4 <150, lasting up to 6 months
- May also involve extraintestinal cryptosporidiosis, such as biliary or respiratory disease
Other immunocompromised patients
- May present similarly to HIV
- Includes solid organ transplant, hematopoietic stem cell transplant, and hyper-IgM syndrome
Diagnosis
- Stool antigen
- Stool with immunofluorescence or with acid-fast staining (70% sensitive)
- PCR
Management
- Supportive care, including fluids and antimotility agents like loperamide
- In immunocompetent hosts: nitazoxanide 500 mg po tid for 3 days
- In severely immunocompromised patients, may not be curable without reversing immunosuppression